Pradaxa Lawsuits

Pradaxa Lawsuit | Pradaxa Bleeding Side Effect
Pradaxa Lawsuits, Pradaxa Bleeding lawsuit, serious internal hemorrhaging
pradaxa-lawsuit-bleeding-attorneyThousands of people have filed Pradaxa lawsuits after suffering life-threatening episodes of uncontrollable internal bleeding that was allegedly caused by the blood-thinning medication. The majority of Pradaxa bleeding claims have been filed in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, where Pradaxa lawsuit trials are scheduled to begin in the fall of 2014. As the Pradaxa litigation continues to prepare for these important trials, it is expected that individuals who were harmed by this drug will continue to file claims in the proceeding.

If you or someone you love experienced serious internal hemorrhaging while using Pradaxa, you can take action. Alleged victims of Pradaxa bleeding can trust Oliver Law Group P.C. to aggressively represent their interests against Boehringer Ingelheim, the manufacturer of the medication. Please contact one of our Pradaxa lawyers today for a free, no obligation review of your case. If you have a valid claim and decide to pursue your Pradaxa bleeding lawsuit, you can be confident that the legal staff at Oliver Law Group P.C. will work to ensure that you are treated fairly and receive the justice you deserve.

Pradaxa Bleeding Side Effects
Pradaxa is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in 2010 to lessen the risk of strokes in people with atrial fibrillation. However, in September 2012, an article published in The Journal for The American Medical Association raised concerns that the FDA may have been too quick to approve Pradaxa. Among other things, the article asserted that the agency had overlooked risks associated with the medication, including a lack of reversal agent for Pradaxa bleeding.

Pradaxa was supposed to be a replacement for and improvement over warfarin. Also sold as Coumadin, warfarin has been in use for decades, and like Pradaxa, it may cause internal bleeding. However, warfarin bleeding can be stopped with vitamin K. No similar antidote yet exists for Pradaxa bleeding.

According to data from the FDA’s Adverse Event Database, Pradaxa was named in 12,494 injury reports between 2011 and 2012. These reports included 1,158 deaths. No other prescription drug on the market was associated with as many adverse events during that time period.

Pradaxa MDL Litigation
By February 2014, more than 2,300 Pradaxa lawsuits had been filed in the federal multidistrict litigation underway in the Southern District of Illinois. All of the lawsuits claim Pradaxa caused patients to suffer dangerous instances of internal bleeding, including cerebral hemorrhage and gastrointestinal bleeding. Documents unsealed in the course of the litigation indicate that the manufacturer of Pradaxa may have withheld data from the FDA which indicated the drug posed a greater bleeding risk to some patients than previously thought.
The first federal trial of a Pradaxa lawsuit is scheduled to begin in September 2014, with others to follow in December 2014, February 2015, and March 2015. These trials will be used to gauge how other juries might rule in similar Pradaxa lawsuits.

Contact Oliver Law Group P.C. to Learn More about Filing a Pradaxa Lawsuit
Oliver Law Group P.C. is a different kind of national law firm. One that focuses on the needs of the injured first. A compassionate law firm dedicated to fighting for the rights of victims and their families, and doing everything necessary to ensure those rights. 

The experience of a large firm. The 1-on-1 dedication of a small firm. A reputation built on trust. Oliver Law Group P.C.
Experience. Dedication. Trust. Oliver Law Group P.C.

If you would like to learn more about filing a Pradaxa lawsuit, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact the Oliver Law Group P.C. for your free case review by calling 1-(800) 939-7878 today.

Leave a Reply

Your email address will not be published. Required fields are marked *

Menu Title